Yüklüyor......
Mechanism of Action of the Ribopyranoside Benzimidazole GW275175X against Human Cytomegalovirus
New human cytomegalovirus (HCMV) therapies with novel mechanisms of action are needed to treat drug-resistant HCMV that arises during therapy with currently approved agents. 2-Bromo-5,6-dichloro-1-β-d-ribofuranosyl-1H-benzimidazole (BDCRB) is an effective anti-HCMV agent with a novel mechanism of ac...
Kaydedildi:
| Asıl Yazarlar: | , , , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
American Society for Microbiology
2004
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC400548/ https://ncbi.nlm.nih.gov/pubmed/15105116 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.48.5.1647-1651.2004 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|